Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2014 Nov 4;186(16):1225-34.
doi: 10.1503/cmaj.140703. Epub 2014 Oct 27.

Recommendations on screening for prostate cancer with the prostate-specific antigen test

Neil Bell  1 , Sarah Connor Gorber  1 , Amanda Shane  1 , Michel Joffres  1 , Harminder Singh  1 , James Dickinson  1 , Elizabeth Shaw  1 , Lesley Dunfield  1 , Marcello Tonelli  1 ; Canadian Task Force on Preventive Health Care
Collaborators, Affiliations
Practice Guideline

Recommendations on screening for prostate cancer with the prostate-specific antigen test

Neil Bell et al. CMAJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per 100 000 men), among Canadian men aged 45 years and older. Age was standardized to the 1991 Canadian population. Incidence data were not available for Quebec from 2008 to 2010; therefore, the population denominator for age-standardized incidence was adjusted and case counts for 2008–2010 were omitted. Mortality data were available only to 2009.
See this image and copyright information in PMC

Comment in

References

    1. Canadian Cancer Society Advisory Committee on Cancer Statistics. Canadian cancer statistics 2013. Toronto: Canadian Cancer Society; 2013. ISSN .
    1. Canadian cancer statistics 2011 [Table 6.1]. Toronto: Canadian Cancer Society; 2011. Available: www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Can... (accessed 2014 Sept. 22).
    1. Powell IJ, Bock CH, Ruterbusch JJ, et al. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white american men, and influences racial progression and mortality disparity. J Urol 2010;183:1792–6. - PMC - PubMed
    1. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from the US prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981–90. - PubMed
    1. Bangma CH, Roemeling S, Schroder FH. Overdiagnosis and overtreatment of early detected prostate cancer. World J Urol 2007;25:3–9. - PMC - PubMed

Publication types

Substances

Grants and funding